• Am Mindfulness featured in Leading COVID-19 Health App Formulary

  • April 23, 2020

    As the number of confirmed cases of novel coronavirus (COVID-19) continues to rise across the globe and governments ask people to stay at home, digital health resources offer practical tools that can be called upon for remote self-management. To help healthcare professionals and consumers know which health apps they can trust, the Organisation for the Review of Care and Health Apps (ORCHA) has launched a health app formulary – a free to use resource listing health apps relevant to the COVID-19 pandemic. ORCHA measures the health of health apps, verifying the accuracy, security, and risks associated with their use. Topping the list in the categories of stress, mindfulness and anxiety is Am Mindfulness, ranking above mass market wellness apps Headspace and Calm in the categories of privacy, security and user experience.

    Mobio Interactive (MI) is a digital therapeutics company that develops and commercialises clinically validated and objectively quantified software to prevent, measure and treat mental illness.


    Am Mindfulness is a clinically validated digital therapeutic that uses remote, objective and scalable measurements of mental health to personalise resilience training. Am is currently available in English, Mandarin, Dutch and German.


    Founded by NHS clinicians, ORCHA is the world’s leading health app evaluation and distribution organisation. Part of the NHS Innovation Accelerator Programme, ORCHA provides services to the NHS in 50% of regions in the UK, providing app libraries and professional recommendation tools across a broad range of settings. It runs national health app accreditation schemes to national bodies worldwide. Its unique review engine tests apps against 260 elements across clinical assurance, data privacy and user experience, plus additional criteria depending on needs. It reviews around 500 apps every month, including automatic re-reviews of apps when they are updated.